270 related articles for article (PubMed ID: 27782879)
1. Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons.
Sampathkumar C; Wu YJ; Vadhvani M; Trimbuch T; Eickholt B; Rosenmund C
Elife; 2016 Oct; 5():. PubMed ID: 27782879
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.
Ogier M; Wang H; Hong E; Wang Q; Greenberg ME; Katz DM
J Neurosci; 2007 Oct; 27(40):10912-7. PubMed ID: 17913925
[TBL] [Abstract][Full Text] [Related]
3. Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice.
Kline DD; Ogier M; Kunze DL; Katz DM
J Neurosci; 2010 Apr; 30(15):5303-10. PubMed ID: 20392952
[TBL] [Abstract][Full Text] [Related]
4. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.
Larimore JL; Chapleau CA; Kudo S; Theibert A; Percy AK; Pozzo-Miller L
Neurobiol Dis; 2009 May; 34(2):199-211. PubMed ID: 19217433
[TBL] [Abstract][Full Text] [Related]
5. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
[TBL] [Abstract][Full Text] [Related]
6. A BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome.
Kron M; Lang M; Adams IT; Sceniak M; Longo F; Katz DM
Dis Model Mech; 2014 Sep; 7(9):1047-55. PubMed ID: 25147297
[TBL] [Abstract][Full Text] [Related]
7. Restoring Wnt6 signaling ameliorates behavioral deficits in MeCP2 T158A mouse model of Rett syndrome.
Hsu WL; Ma YL; Liu YC; Tai DJC; Lee EHY
Sci Rep; 2020 Jan; 10(1):1074. PubMed ID: 31974426
[TBL] [Abstract][Full Text] [Related]
8. Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling.
Miranda-Lourenço C; Duarte ST; Palminha C; Gaspar C; Rodrigues TM; Magalhães-Cardoso T; Rei N; Colino-Oliveira M; Gomes R; Ferreira S; Rosa J; Xapelli S; Armstrong J; García-Cazorla À; Correia-de-Sá P; Sebastião AM; Diógenes MJ
Neurobiol Dis; 2020 Nov; 145():105043. PubMed ID: 32798727
[TBL] [Abstract][Full Text] [Related]
9. Restoration of motor learning in a mouse model of Rett syndrome following long-term treatment with a novel small-molecule activator of TrkB.
Adams I; Yang T; Longo FM; Katz DM
Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 33361117
[TBL] [Abstract][Full Text] [Related]
10. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
11. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice.
Wang H; Chan SA; Ogier M; Hellard D; Wang Q; Smith C; Katz DM
J Neurosci; 2006 Oct; 26(42):10911-5. PubMed ID: 17050729
[TBL] [Abstract][Full Text] [Related]
13. Differential Expression and Regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA Isoforms in Brain Cells from Mecp2(308/y) Mouse Model.
Rousseaud A; Delépine C; Nectoux J; Billuart P; Bienvenu T
J Mol Neurosci; 2015 Aug; 56(4):758-767. PubMed ID: 25634725
[TBL] [Abstract][Full Text] [Related]
14. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
15. MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production.
Abuhatzira L; Makedonski K; Kaufman Y; Razin A; Shemer R
Epigenetics; 2007; 2(4):214-22. PubMed ID: 18075316
[TBL] [Abstract][Full Text] [Related]
16. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
[TBL] [Abstract][Full Text] [Related]
17. A small-molecule TrkB ligand restores hippocampal synaptic plasticity and object location memory in Rett syndrome mice.
Li W; Bellot-Saez A; Phillips ML; Yang T; Longo FM; Pozzo-Miller L
Dis Model Mech; 2017 Jul; 10(7):837-845. PubMed ID: 28679669
[TBL] [Abstract][Full Text] [Related]
18. A small-molecule TrkB ligand improves dendritic spine phenotypes and atypical behaviors in female Rett syndrome mice.
Medeiros D; Ayala-Baylon K; Egido-Betancourt H; Miller E; Chapleau C; Robinson H; Phillips ML; Yang T; Longo FM; Li W; Pozzo-Miller L
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38785269
[TBL] [Abstract][Full Text] [Related]
19. Modification of Mecp2 dosage alters axonal transport through the Huntingtin/Hap1 pathway.
Roux JC; Zala D; Panayotis N; Borges-Correia A; Saudou F; Villard L
Neurobiol Dis; 2012 Feb; 45(2):786-95. PubMed ID: 22127389
[TBL] [Abstract][Full Text] [Related]
20. Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of
Miranda-Lourenço C; Rosa J; Rei N; Belo RF; Lopes AL; Silva D; Vieira C; Magalhães-Cardoso T; Viais R; Correia-de-Sá P; Sebastião AM; Diógenes MJ
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]